...
首页> 外文期刊>Developmental biology >ENDOGENOUS BASIC FIBROBLAST GROWTH FACTOR IS IMPLICATED IN THE VASCULARIZATION OF THE CHICK EMBRYO CHORIOALLANTOIC MEMBRANE
【24h】

ENDOGENOUS BASIC FIBROBLAST GROWTH FACTOR IS IMPLICATED IN THE VASCULARIZATION OF THE CHICK EMBRYO CHORIOALLANTOIC MEMBRANE

机译:内源性碱性成纤维细胞生长因子与小鸡胚变铝膜的血管形成有关

获取原文
获取原文并翻译 | 示例
           

摘要

Chorioallantoic membrane (CAM) and chorioallantoic fluid (CAF) of the chick embryo were studied for the presence of immunoreactive and biologically active basic fibroblast growth factor (bFGF) from Day 6 to Day 18 of incubation. An immunoreactive M(r) 16,000 bFGF-like molecule was detected both in CAM and in CAF. This molecule was identified as bFGF on the basis of its molecular weight, its affinity for heparin, and its capacity to induce plasminogen activator production in cultured endothelial GM 7373 cells. The levels of biologically active and immunoreactive bFGF vary in CAM and CAF during embryonic development, maximal concentrations being observed between Days 10 and 14 of incubation. At all time points investigated, absolute concentrations of bFGF were significantly higher in CAM (ranging from 25 to 183 ng/g of wet tissue) than in CAF (ranging from 0.2 to 4 ng/ml). In a parallel series of experiments performed at Day 8 and evaluated at Day 12 of chick embryo development, human recombinant bFGF and neutralizing anti-bFGF antibody were investigated for their capacity to affect the vasoproliferative processes of the CAM. The two molecules either were applied onto the surface of the CAM or were injected into the allantoic sac. When bFGF or anti-bFGF antibodies were absorbed on methylcellulose discs and applied on the top of the CAM, they exerted a strong angiogenic or anti-angiogenic effect, respectively. On the contrary, when bFGF or the corresponding neutralizing antibody was injected into the allantoic sac, no modidcations of the vasoproliferative processes of the CAM were observed at either the macroscopic or the microscopic level. These results provide evidence indicating that endogenous bFGF has a rate-limiting role in the vascularization of the CAM during chick embryogenesis. bFGF located within the CAM, rather than that present in the CAF, appears to be involved in this developmental process. (C) 1995 Academic Press, Inc. [References: 62]
机译:从孵化的第6天到第18天,研究了鸡胚的绒毛膜尿囊膜(CAM)和绒毛膜尿囊液(CAF)是否存在免疫反应性和生物活性碱性成纤维细胞生长因子(bFGF)。在CAM和CAF中都检测到了具有免疫反应性的M(r)16,000 bFGF样分子。根据其分子量,对肝素的亲和力以及在培养的内皮GM 7373细胞中诱导纤溶酶原激活物产生的能力,该分子被鉴定为bFGF。在胚胎发育过程中,CAM和CAF中的生物活性和免疫反应性bFGF含量有所不同,在孵育的第10天到第14天之间观察到了最大浓度。在所有调查的时间点上,CAM中bFGF的绝对浓度(湿组织为25至183 ng / g)显着高于CAF中bFGF的绝对浓度(0.2至4 ng / ml)。在第8天进行的平行实验中,并在雏鸡胚胎发育的第12天进行了评估,研究了人类重组bFGF和中和性抗bFGF抗体影响CAM血管增生过程的能力。这两个分子要么被施加到CAM的表面上,要么被注入尿囊囊中。当bFGF或抗bFGF抗体被吸收在甲基纤维素盘上并应用于CAM的顶部时,它们分别发挥了强大的血管生成或抗血管生成作用。相反,当将bFGF或相应的中和抗体注入​​尿囊囊中时,在宏观或微观水平上均未观察到CAM的血管增生过程的修饰。这些结果提供了证据,表明内源性bFGF在雏鸡胚胎发生过程中对CAM的血管形成具有限速作用。位于CAM中而不是CAF中的bFGF似乎参与了这一发育过程。 (C)1995 Academic Press,Inc. [参考:62]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号